Insight into drug resistance mechanisms and discovery of potential inhibitors against wild-type and L1196M mutant ALK from FDA-approved drugs
Crossref DOI link: https://doi.org/10.1007/s00894-016-3099-5
Published Online: 2016-09-01
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Jianzong
Liu, Wei
Luo, Hao
Bao, Jinku
Funding for this research was provided by:
the National Natural Science Foundation of China (No. 81173093)
License valid from 2016-09-01